Policy Change

LIXIL has reached 103 million people with safe sanitation, not through charity, but by building a revolutionary social business from the ground up.

The diagnostics firm has 180 days to boost its market value after a Nasdaq warning, placing immense pressure on its turnaround and high-stakes biosensor plans.

The company shed debt and unprofitable revenue in 2025, betting its future on its VLN® cigarette ahead of a potential FDA nicotine crackdown.

A new report reveals supporting family caregivers isn't just compassionate—it's a financially sound strategy for hospitals to cut costs and improve care.

BitGo and New Frontier Labs are launching FYUSD, a stablecoin bringing U.S. regulatory standards to Asia and paving the way for AI-driven finance.

With a 10x surge in transaction volume, Pay Protocol's success on TRON highlights a quiet revolution in business finance, powered by stablecoins.

The junior explorer secures crucial funding from a renowned investor, fueling its nickel-copper ambitions in Canada's critical mineral heartland.

A new partnership will supply Japan's surging cell therapy sector with critical, GMP-grade materials, aiming to accelerate the path from lab to clinic.

Telehealth firm MangoRx reports explosive growth with its $99/month TRT program, challenging competitors and raising questions about the future of virtual care.

As AI adoption outpaces policy, a new legal practice aims to bridge the governance gap, offering a practical playbook for businesses in a new legal frontier.

ZenaTech seeks Green UAS certification for its ZD1000 drone, a strategic move to enter the lucrative and secure U.S. government and defense market.

An independent candidate proposes a $50,000 graduate dividend, funded by redirecting billions in offshore pension wealth to tackle youth disenfranchisement.

Facing shrinking margins and investor demands, healthcare leaders are ditching AI experiments for automation that delivers immediate financial lift and audit-ready results.

Engineering giant STV unveils its 'Performance Accelerated' plan, betting on power services, tech, and talent to navigate North America's complex future.

The spatial biology leader will unveil its roadmap at AGBT 2026, targeting the next frontiers of drug discovery with 3D imaging and human-relevant models.

Princeton NuEnergy hires a battery industry titan to spearhead its commercial push, aiming to dominate the booming U.S. battery recycling market.

Five Alberta First Nations launch a legal challenge against a federal-provincial deal, citing a lack of consent for the world's largest proposed CCS project.

Alta is set to reveal its full-year 2025 results after a year of strategic pivots. Investors will watch for signs of recovery and strategic progress.

Amid regional conflict, InterCure reports NIS 265M revenue, enters German market, and makes strategic US moves, showcasing remarkable resilience and growth.

Israeli cannabis firm InterCure posts 11% revenue growth in 2025, showing resilience after conflict and making its first major push into the booming German market.